| 1 |
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
Katherine K. Matthay, Judith Grob Villablanca, Robert C. Seeger et al. · New England Journal of Medicine
Open access |
14 Oct 1999 |
1,915 |
| 2 |
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Charles Grenfell Mullighan et al. · New England Journal of Medicine
Open access |
7 Jan 2009 |
1,459 |
| 3 |
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Kathryn G. Roberts et al. · New England Journal of Medicine
Open access |
11 Sep 2014 |
1,391 |
| 4 |
The International Neuroblastoma Pathology Classification (the Shimada system)
Hiroyuki Shimada, Inge M. Ambros, Louis P. Dehner et al. · Cancer
|
15 Jul 1999 |
1,042 |
| 5 |
The Third Intergroup Rhabdomyosarcoma Study.
W M Crist, E. A. Gehan, A H Ragab et al. · Journal of Clinical Oncology
|
Mar 1995 |
1,013 |
| 6 |
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al. · Nature
Open access |
Oct 2008 |
903 |
| 7 |
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Hamid Bolouri et al. · Nature Medicine
Open access |
11 Dec 2017 |
900 |
| 8 |
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J. Borowitz, Meenakshi Devidas, Stephen P. Hunger et al. · Blood
Open access |
4 Apr 2008 |
849 |
| 9 |
Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology
Open access |
30 Jan 2008 |
756 |
| 10 |
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
Sigbjørn Smeland et al. · European Journal of Cancer
Open access |
27 Jan 2019 |
748 |
| 11 |
The intergroup rhabdomyosarcoma study-II
Harold M. Maurer et al. · Cancer
|
Mar 1993 |
740 |
| 12 |
Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate
Paul A. Meyers et al. · Journal of Clinical Oncology
Open access |
18 Mar 2005 |
724 |
| 13 |
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Yaël P. Mossé, Megan S. Lim, Stephan D. Voss et al. · The Lancet Oncology
Open access |
17 Apr 2013 |
714 |
| 14 |
A Comparison of Conservative and Aggressive Transfusion Regimens in the Perioperative Management of Sickle Cell Disease
Elliott P. Vichinsky, Charles M. Haberkern, Lynne Neumayr et al. · New England Journal of Medicine
Open access |
27 Jul 1995 |
657 |
| 15 |
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
Kayla L. Nguyen, Meenakshi Devidas, Cheng Sc et al. · Leukemia
Open access |
25 Sep 2008 |
592 |
| 16 |
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
Edward F. Attiyeh, Wendy B. London, Yaël P. Mossé et al. · New England Journal of Medicine
Open access |
23 Nov 2005 |
580 |
| 17 |
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
Richard C. Harvey, Charles Grenfell Mullighan, I‐Ming Chen et al. · Blood
Open access |
5 Feb 2010 |
576 |
| 18 |
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al. · Nature Genetics
Open access |
29 Jun 2015 |
568 |
| 19 |
JAK mutations in high-risk childhood acute lymphoblastic leukemia
Charles Grenfell Mullighan et al. · Proceedings of the National Academy of Sciences
Open access |
22 May 2009 |
563 |
| 20 |
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Neyssa M. Marina et al. · The Lancet Oncology
Open access |
31 Aug 2016 |
559 |
| 21 |
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an intergroup rhabdomyosarcoma study
William A. Newton, Edmund A. Gehan, Bruce L. Webber et al. · Cancer
|
15 Sep 1995 |
559 |
| 22 |
Second Neoplasms after Acute Lymphoblastic Leukemia in Childhood
Joseph P. Neglia, Anna T. Meadows, Leslie L. Robison et al. · New England Journal of Medicine
Open access |
7 Nov 1991 |
550 |
| 23 |
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock, Mei K. L. La, Ben L. Sanford et al. · Blood
Open access |
24 May 2008 |
538 |
| 24 |
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Meredith S. Irwin, Arlene H. Naranjo, Fan F. Zhang et al. · Journal of Clinical Oncology
Open access |
28 Jul 2021 |
505 |
| 25 |
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
Vassilios I. Avramis, Susan Sencer, Antonia P. Periclou et al. · Blood
|
15 Mar 2002 |
501 |
| 26 |
Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease
Cameron K. Tebbi, Wendy B. London, Debra L. Friedman et al. · Journal of Clinical Oncology
Open access |
8 Feb 2007 |
493 |
| 27 |
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi et al. · Journal of Clinical Oncology
Open access |
5 Aug 2014 |
489 |
| 28 |
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
Kirk R. Schultz, DJ Pullen, Harland N. Sather et al. · Blood
Open access |
26 Sep 2006 |
479 |
| 29 |
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
Kirk R. Schultz, Andrew J. Carroll, Nyla A. Heerema et al. · Leukemia
Open access |
20 Jan 2014 |
453 |
| 30 |
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration
Rebecka L. Meyers et al. · The Lancet Oncology
Open access |
21 Nov 2016 |
451 |
| 31 |
Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy
James B. Nachman, Harland N. Sather, Martha G. Sensel et al. · New England Journal of Medicine
Open access |
4 Jun 1998 |
451 |
| 32 |
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
Brian V. Balgobind et al. · Blood
Open access |
15 Jun 2009 |
451 |
| 33 |
Residential Exposure to Magnetic Fields and Acute Lymphoblastic Leukemia in Children
Martha S. Linet, Elizabeth Elliott Hatch, Ruth A. Kleinerman et al. · New England Journal of Medicine
Open access |
3 Jul 1997 |
422 |
| 34 |
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
Peter F. Ambros, I.M. Ambros, G M Brodeur et al. · British Journal of Cancer
Open access |
28 Apr 2009 |
409 |
| 35 |
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
Richard C. Harvey et al. · Blood
Open access |
11 Aug 2010 |
408 |
| 36 |
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
Victor A. Levin, Pamela Silver, John F. Hannigan et al. · International Journal of Radiation Oncology*Biology*Physics
|
Feb 1990 |
404 |
| 37 |
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
Kenneth J. Cohen, Ian F. Pollack, T. Zhou et al. · Neuro-Oncology
Open access |
21 Feb 2011 |
402 |
| 38 |
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
Bayard L. Powell, Barry Kurt Moser, Wendy Stock et al. · Blood
Open access |
13 Aug 2010 |
400 |
| 39 |
Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials
W. Archie Bleyer · Medical and Pediatric Oncology
|
21 Dec 2001 |
394 |
| 40 |
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler, Daniel A. Weiser, Peter J. Huwe et al. · Cancer Cell
Open access |
Nov 2014 |
394 |
| 41 |
Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine
Edith A. Perez, Guillermo Luis Lerzo, Xavier B. Pivot et al. · Journal of Clinical Oncology
Open access |
3 Jul 2007 |
393 |
| 42 |
Adolescents and young adults with cancer
Archie Bleyer, Troy Budd, Michael J. Montello · Cancer
Open access |
2006 |
390 |
| 43 |
The genetic basis and cell of origin of mixed phenotype acute leukaemia
Thomas Alexander et al. · Nature
Open access |
11 Sep 2018 |
384 |
| 44 |
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia
Patrick Andrew Brown, Lingyun Ji, Xinxin Xu et al. · JAMA
Open access |
2 Mar 2021 |
381 |
| 45 |
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma
Julie R. Park, Susan G. Kreissman, Wendy B. London et al. · JAMA
Open access |
27 Aug 2019 |
369 |
| 46 |
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Bruce Bostrom · Blood
|
16 Jan 2003 |
362 |
| 47 |
Copy number variation at 1q21.1 associated with neuroblastoma
Sharon J. Diskin et al. · Nature
Open access |
Jun 2009 |
361 |
| 48 |
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
Kenneth J. Cohen, Richard L. Heideman, T. Zhou et al. · Neuro-Oncology
Open access |
22 Feb 2011 |
349 |
| 49 |
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
Julie R. Park, Rochelle Bagatell, Wendy B. London et al. · Pediatric Blood & Cancer
|
19 Dec 2012 |
347 |
| 50 |
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial
Kara Lynn Davis, Elizabeth Fox, Melinda S. Merchant et al. · The Lancet Oncology
Open access |
17 Mar 2020 |
344 |